Since 2011 Synthelia Organics has been committed to providing synthetic solutions to our customers in the pharmaceutical and biotech industry from research and development to manufacturing. In 2022 we inaugurate the new facilities with more than 1700 m2 distributed between R&D laboratories, pilot plant, production, quality and analytical.
Our History
Our Team
• Research team composed of 38% PhD 62% MsC. 40% female 60% male with extensive knowledge acquired in custom synthesis, route optimization and development of safety processes.
• Experience acquired as part of the R&D teams of companies such as Lilly, Novartis, GSK, Janssen, Roche…
• In continuous training driven by personalised professional development plans.
• Staff trained for mg to multiKg synthesis.
• Experienced in handling potentially hazardous reactions, pressure reactions…
• Expertise in the use of synthesis tools such as flow reactors.
Our values
Honesty
We generate trust and closeness through fluid communication, with a transparent delivery of the product or process as agreed and, of course, with absolute confidentiality.
Creative
We like a challenge. We are motivated to contribute with creativity during the design and development of synthetic routes that solve the challenges that appear in your project.
Commitment
We share the results with you in real time. We are very proactive, collaborating in decision making as you need it.
Detail-oriented
Focused and committed to quality through a quality management system aligned with a GMP culture throughout the process and especially in the production phase.
Dynamic
In R&D environments change is continuous, so we focus on being dynamic and adapting to the changing priorities of your project.
Let’s connect!
We’d love to help you.
Quam pellentesque nec nam aliquam. Sit amet consectetur adipiscing elit duis tristique sollicitudin.